Bal Pharma Limited

NSEI:BALPHARMA 주식 보고서

시가총액: ₹2.1b

Bal Pharma 관리

관리 기준 확인 3/4

Bal Pharma CEO는 Shailesh Siroya, Aug2019 에 임명되었습니다 의 임기는 5.25 년입니다. 총 연간 보상은 ₹ 10.20M, 100% 로 구성됩니다. 100% 급여 및 0% 보너스(회사 주식 및 옵션 포함). 는 ₹ 399.11M 가치에 해당하는 회사 주식의 19.27% 직접 소유합니다. 399.11M. 경영진과 이사회의 평균 재임 기간은 각각 4.2 년과 4.5 년입니다.

주요 정보

Shailesh Siroya

최고 경영자

₹10.2m

총 보상

CEO 급여 비율100.0%
CEO 임기5.3yrs
CEO 소유권19.3%
경영진 평균 재임 기간4.2yrs
이사회 평균 재임 기간4.5yrs

최근 관리 업데이트

Here's Why Shareholders May Want To Be Cautious With Increasing Bal Pharma Limited's (NSE:BALPHARMA) CEO Pay Packet

Sep 19
Here's Why Shareholders May Want To Be Cautious With Increasing Bal Pharma Limited's (NSE:BALPHARMA) CEO Pay Packet

Bal Pharma Limited's (NSE:BALPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 18
Bal Pharma Limited's (NSE:BALPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

Recent updates

Here's Why Shareholders May Want To Be Cautious With Increasing Bal Pharma Limited's (NSE:BALPHARMA) CEO Pay Packet

Sep 19
Here's Why Shareholders May Want To Be Cautious With Increasing Bal Pharma Limited's (NSE:BALPHARMA) CEO Pay Packet

Bal Pharma (NSE:BALPHARMA) Is Increasing Its Dividend To ₹1.20

Aug 31
Bal Pharma (NSE:BALPHARMA) Is Increasing Its Dividend To ₹1.20

Bal Pharma Limited's (NSE:BALPHARMA) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Aug 27
Bal Pharma Limited's (NSE:BALPHARMA) Share Price Boosted 25% But Its Business Prospects Need A Lift Too

Bal Pharma (NSE:BALPHARMA) Is Paying Out A Larger Dividend Than Last Year

Aug 15
Bal Pharma (NSE:BALPHARMA) Is Paying Out A Larger Dividend Than Last Year

Insufficient Growth At Bal Pharma Limited (NSE:BALPHARMA) Hampers Share Price

May 30
Insufficient Growth At Bal Pharma Limited (NSE:BALPHARMA) Hampers Share Price

Does Bal Pharma (NSE:BALPHARMA) Have A Healthy Balance Sheet?

Mar 14
Does Bal Pharma (NSE:BALPHARMA) Have A Healthy Balance Sheet?

Bal Pharma Limited's (NSE:BALPHARMA) 26% Share Price Surge Not Quite Adding Up

Feb 01
Bal Pharma Limited's (NSE:BALPHARMA) 26% Share Price Surge Not Quite Adding Up

Bal Pharma Limited's (NSE:BALPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 18
Bal Pharma Limited's (NSE:BALPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

Bal Pharma (NSE:BALPHARMA) Is Due To Pay A Dividend Of ₹1.00

Aug 28
Bal Pharma (NSE:BALPHARMA) Is Due To Pay A Dividend Of ₹1.00

Bal Pharma (NSE:BALPHARMA) Is Paying Out A Dividend Of ₹1.00

Aug 14
Bal Pharma (NSE:BALPHARMA) Is Paying Out A Dividend Of ₹1.00

Bal Pharma (NSE:BALPHARMA) Is Paying Out A Dividend Of ₹1.00

Aug 17
Bal Pharma (NSE:BALPHARMA) Is Paying Out A Dividend Of ₹1.00

Bal Pharma (NSE:BALPHARMA) Has Announced A Dividend Of ₹1.00

Jul 31
Bal Pharma (NSE:BALPHARMA) Has Announced A Dividend Of ₹1.00

Is Bal Pharma (NSE:BALPHARMA) Using Too Much Debt?

Mar 08
Is Bal Pharma (NSE:BALPHARMA) Using Too Much Debt?

Bal Pharma (NSE:BALPHARMA) Use Of Debt Could Be Considered Risky

Nov 23
Bal Pharma (NSE:BALPHARMA) Use Of Debt Could Be Considered Risky

Does Bal Pharma Limited (NSE:BALPHARMA) Have A Place In Your Dividend Stock Portfolio?

Aug 10
Does Bal Pharma Limited (NSE:BALPHARMA) Have A Place In Your Dividend Stock Portfolio?

Should You Buy Bal Pharma Limited (NSE:BALPHARMA) For Its 2.3% Dividend?

Aug 10
Should You Buy Bal Pharma Limited (NSE:BALPHARMA) For Its 2.3% Dividend?

CEO 보상 분석

Shailesh Siroya 의 보수는 Bal Pharma 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

₹77m

Jun 30 2024n/an/a

₹76m

Mar 31 2024₹10m₹10m

₹74m

Dec 31 2023n/an/a

₹35m

Sep 30 2023n/an/a

₹32m

Jun 30 2023n/an/a

₹24m

Mar 31 2023₹12m₹12m

₹26m

Dec 31 2022n/an/a

₹29m

Jun 30 2022n/an/a

₹43m

Mar 31 2022₹10m₹10m

₹56m

Dec 31 2021n/an/a

₹72m

Jun 30 2021n/an/a

₹59m

Mar 31 2021₹10m₹10m

₹47m

Dec 31 2020n/an/a

-₹34m

Sep 30 2020n/an/a

-₹73m

Jun 30 2020n/an/a

-₹95m

Mar 31 2020₹10m₹10m

-₹122m

Dec 31 2019n/an/a

-₹52m

Sep 30 2019n/an/a

-₹15m

Jun 30 2019n/an/a

-₹21m

Mar 31 2019₹8m₹8m

₹38m

Dec 31 2018n/an/a

₹29m

Mar 31 2018₹8m₹8m

₹28m

보상 대 시장: Shailesh 의 총 보상 ($USD 120.82K )은 Indian 시장( $USD 42.64K ).

보상과 수익: Shailesh 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Shailesh Siroya (58 yo)

5.3yrs

테뉴어

₹10,200,000

보상

Mr. Shailesh Dheerajmal Siroya serves as the Managing Director of BAL Pharma Limited. Mr. Siroya served as the Managing Director of BAL Pharma Limited since August 1, 1994. With rich experience, Mr. Siroya...

리더십 팀

이름위치테뉴어보상소유권
Shailesh Siroya
MD & Executive Director5.3yrs₹10.20m19.27%
₹ 399.1m
Daddanala Bharath Bhushan
Chief Financial Officerno data₹2.60m데이터 없음
Abdul Basith
Company Secretary & Compliance Officer1.3yrs₹540.00k데이터 없음
Himesh Virupakshaya
Whole Time Director4.2yrs₹3.32m0.17%
₹ 3.5m
Ravindra Kothari
Deputy General Manager of Internal Auditno data데이터 없음데이터 없음
D. Bhat
Assistant Vice President of Sales & Marketingno data데이터 없음데이터 없음
Archana Mitra
Vice President of International Marketing & HRno data₹534.34k데이터 없음
Kotian Damodar
Whole Time Directorno data₹1.87m데이터 없음

4.2yrs

평균 재임 기간

59.5yo

평균 연령

경험이 풍부한 관리: BALPHARMA 의 관리팀은 경험 ( 4.2 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Shailesh Siroya
MD & Executive Director27.2yrs₹10.20m19.27%
₹ 399.1m
Himesh Virupakshaya
Whole Time Director5.2yrs₹3.32m0.17%
₹ 3.5m
Kotian Damodar
Whole Time Director2.5yrs₹1.87m데이터 없음
Nicola Neeladrie
Independent Non-Executive Director4.5yrs₹52.00k데이터 없음
H. Venkatesh
Non-Executive Additional Independent Director4.5yrs₹61.00k데이터 없음
Jatish Sheth
Non-Executive Independent Director3.9yrs₹61.00k데이터 없음

4.5yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 이사회: BALPHARMA 의 이사회는 경험(평균 재직 기간 4.5 년)으로 간주됩니다.